FIELD: medicine; medical engineering.
SUBSTANCE: device has placental glycosaminglycans, glycerin, polyvinyl pyrrolidon, methyl cellulose, nipagin and purified water.
EFFECT: improved usability properties.
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC DROPS | 2002 |
|
RU2216331C1 |
OPHTHALMIC OINTMENT | 1998 |
|
RU2168963C2 |
OPHTHALMIC OINTMENT | 2007 |
|
RU2331408C1 |
EYE DROPS | 1994 |
|
RU2088215C1 |
EYEGEL | 1994 |
|
RU2098079C1 |
BROAD ACTIVITY SPECTRUM MEANS FOR TREATING CUTANEOUS MYCOSES CASES | 2005 |
|
RU2292198C1 |
EYE FILM | 1997 |
|
RU2173178C2 |
OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
AGENT FOR SCABIES TREATMENT | 2001 |
|
RU2210365C1 |
METHOD FOR PRODUCING OPHTHALMIC FILMS | 2004 |
|
RU2314793C2 |
Authors
Dates
2006-10-27—Published
2005-06-17—Filed